|
We are using proteomics based technologies to uncover the mysteries of prostate cancer.
To accomplish this task we use tools such as Ciphergens SELDI-TOF to screen clinical samples and Micromass instruments to characterize proteins of interest.
The basic principles of our strategy and references to recently published works in this area are shown below.
|
